US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

3  4  5  6    8    10  11  12  
PharmaPoint: Ulcerative Colitis - China Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - India Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - 5EU Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 6,995
Irritable Bowel Syndrome - Pipeline Review, H1 2014
3/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Irritable Bowel Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Gastrointestinal Hemorrhage Global Clinical Trials Review, H2, 2013
12/30/2013 | published by: GlobalData
... information and data relating to the clinical trials on Gastrointestinal Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
2014 Analysis of the H. Pylori Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
11/21/2013 | published by: Venture Planning Group
... Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year ...  |  read more...
USD 4,350
H. Pylori Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
1/22/2014 | published by: Venture Planning Group
... in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts ...  |  read more...
USD 4,350
Gastrointestinal Symptoms Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... partnering deals Top gastrointestinal symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastrointestinal Symptoms Partnering 2009-2014 provides understanding and access to the gastrointestinal symptoms partnering deals ...  |  read more...
USD 995
2014 Strategies for the H. Pylori Diagnostic Testing Market
1/29/2014 | published by: Venture Planning Group
... views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Physician Offices - ...  |  read more...
USD 4,350
Fiber Food Ingredients in the U.S.: Soluble, Insoluble, and Digestive-Resistant Types, 2nd Edition
11/16/2012 | published by: Packaged Facts
... explores the finished products in the marketplace and the Americans that purchase them. The report provides insight to the types of fiber and their proven benefit; the companies that supply the ingredients, including a competitive ...  |  read more...
USD 3,995
Dyspepsia – Pipeline Review, H2 2012
10/31/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dyspepsia. Dyspepsia - Pipeline Review, Half Year is built using data and information ...  |  read more...
USD 2,000
Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market
11/1/2012 | published by: GBI Research
... its latest research, “Gastrointestinal Disorders Therapeutics Market to 2018 - Novel Agents Targeting Irritable Bowel Syndrome (IBS), Chronic Constipation (CC) and Ulcerative Colitis (UC) to Reinvigorate the Market”, which provides insights into the gastrointestinal disorders ...  |  read more...
USD 3,500
Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth
11/9/2012 | published by: GBI Research
... has released its latest research, “Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth”. It provides in-depth ...  |  read more...
USD 3,500
Global Gastrointestinal Devices Market 2012-2016
7/5/2013 | published by: TechNavio - Infiniti Research Ltd.
... prevalence of GI disorders The Global GI Devices market has also been witnessing an increasing demand for minimally invasive procedures. However, the presence of alternative procedures could pose a challenge to the growth of this ...  |  read more...
USD 2,500
Digestive Remedies in Croatia
3/4/2013 | published by: Euromonitor International
... to a variety of minor digestive ailments. On the other hand, it can also be attributed to the changing parental views of how and when to administer medication to children. Euromonitor International's Digestive Remedies in ...  |  read more...
USD 900
Constipation Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Constipation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD)
4/10/2013 | published by: Timely Data Resources, Inc.
... A review of causes and concomitant diseases and conditions are also presented. Dosing and treatment cost information is provided for various treatment types. General information on the GERD market, as well as sales of leading ...  |  read more...
USD 950
Gastrointestinal Devices: World Market 2013-2023
3/6/2013 | published by: Visiongain
... explains trends, opportunities and prospects for gastrointestinal devices. There's rising demand for those products. Our study lets you assess sales data at overall world market, submarket and national level. There you find that industry's most ...  |  read more...
USD 2,837
Inflammatory Bowel Diseases: World Drug Market 2013-2023
7/18/2013 | published by: Visiongain
... from 2013, helping you stay ahead. There you find financial results, R&D trends, opportunities, and potential revenues. In that work you see forecasted sales to 2023 at overall world market, submarket, product, and national level. ...  |  read more...
USD 2,837
Digestive Remedies in Azerbaijan
9/1/2013 | published by: Euromonitor International
... a positive environment for the development of the category. The increasingly hectic pace of life in Azerbaijan is associated with changing nutrition habits and there is a marked shift away from traditional sit-down meals towards ...  |  read more...
USD 900
Digestive Remedies in Poland
4/11/2013 | published by: Euromonitor International
... Poles eat on the go and reach for fast food. In addition, many consume alcoholic drinks and smoke on a regular basis. All of these prompt a growing number of various digestive disorders, including heartburn, ...  |  read more...
USD 900
Digestive Remedies in Hungary
7/1/2013 | published by: Euromonitor International
... to strengthen their category position with mass advertising activities. Although more brands in proton pump inhibitors have received a trade licence from the National Institute of Pharmacology, they have still not been introduced onto the ...  |  read more...
USD 900
Digestive Remedies in Italy
7/1/2013 | published by: Euromonitor International
... to herbal alternatives. Antacids, by contrast, was shaken by the switch of Maalox from prescription to non-prescription, and its consequent significant decrease in retail price, which jeopardised the growth of proton pump inhibitors, which showed ...  |  read more...
USD 900
Digestive Remedies in Thailand
7/4/2013 | published by: Euromonitor International
... chronic heartburn symptoms. During the review period, digestive remedies products were considered as a necessity for Thais who could not successfully adjust their lifestyles to a work-life balance. Euromonitor International's Digestive Remedies in Thailand report ...  |  read more...
USD 900
3  4  5  6    8    10  11  12